Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,037,630 papers from all fields of science
Search
Sign In
Create Free Account
naltrexonazine
Known as:
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, ((5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-ylidene)hydrazone, (5alpha)-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Naltrexone
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The role of the mu 2-opioid receptor in the antitussive effect of morphine in mu 1-opioid receptor-deficient CXBK mice.
J. Kamei
,
Y. Iwamoto
,
T. Suzuki
,
M. Misawa
,
H. Nagase
,
Y. Kasuya
European Journal of Pharmacology
1993
Corpus ID: 4531285
1992
1992
Opioid mu-deficient CXBK mouse and the role of mu 1-receptors in electrically induced convulsions.
H. Yokoyama
,
K. Onodera
,
T. Suzuki
,
K. Iinuma
,
T. Watanabe
Brain Research
1992
Corpus ID: 39040240
Studies were made on the role of mu 1-receptors on electrically induced convulsions in mice. A relatively selective mu 1-agonist…
Expand
1989
1989
Transfer of fatty acyl groups from membrane phosphatides to opiate ligands
A. Garzon-Aburbeh
,
A. Lipkowski
,
D. L. Larson
,
P. Portoghese
Neurochemistry International
1989
Corpus ID: 8264959
1987
1987
X-ray crystal structure of the opioid ligand naltrexonazine.
Z. Urbańczyk-Lipkowska
,
A. Lipkowski
,
M. C. Etter
,
E. Hahn
,
G. Pasternak
,
P. Portoghese
Journal of Medicinal Chemistry
1987
Corpus ID: 12944308
The anti-anti isomer of naltrexonazine (1) was synthesized, and its configuration was confirmed by X-ray crystallography. The syn…
Expand
1987
1987
Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
S. Galetta
,
E. Hahn
,
S. Nishimura
,
G. Pasternak
Life Science
1987
Corpus ID: 39877413
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE